{"id":1685,"date":"2022-06-11T12:13:13","date_gmt":"2022-06-11T10:13:13","guid":{"rendered":"https:\/\/www.guiafc.es\/empresa-comun-para-la-iniciativa-sobre-medicamentos-innovadores-imi\/"},"modified":"2022-07-11T12:34:37","modified_gmt":"2022-07-11T10:34:37","slug":"empresa-comun-para-la-iniciativa-sobre-medicamentos-innovadores-imi","status":"publish","type":"post","link":"https:\/\/www.guiafc.es\/en\/empresa-comun-para-la-iniciativa-sobre-medicamentos-innovadores-imi\/","title":{"rendered":"Innovative Medicines Innitiative (IMI)"},"content":{"rendered":"<div>\n<div class=\"page\" title=\"Page 10\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The Innovative Medicines Initiative Joint Undertaking (IMI Joint Undertaking) supports collaborative research to improve the entire development process and make it more efficient, accelerating patients' access to better and safer medicines. Its function is none other than to promote the development of medicines, facilitating open collaboration in research.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div>\n<h4><strong>CALLS FOR PROPOSALS<\/strong><\/h4>\n<p>Calls are published regularly on the innitiative's <a href=\"http:\/\/www.aal-europe.eu\/stay-up-to-date\/calls\/\">website<\/a>.<\/p>\n<h4>LEGAL BASIS<\/h4>\n<p id=\"title\" class=\"title-bold\">Council Regulation 557\/2014 of 6 May 2014 establishing the Innovative Medicines Initiative 2 Joint Undertaking\u00a0| \u00a0<a href=\"http:\/\/data.europa.eu\/eli\/reg\/2014\/557\/oj\">DOUE L 169\/54 de 7.6.2014<\/a><\/p>\n<p><iframe loading=\"lazy\" title=\"IMI is public, private, prepared\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/q3VqItI8eyY?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<\/div>\n<\/div>\n<hr \/>\n<p><strong>General information<\/strong><\/p>\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"informacion-general\" class=\"tab-pane rl_tabs-pane nn_tabs-pane orange active\" role=\"tabpanel\" aria-labelledby=\"tab-informacion-general\" aria-hidden=\"false\">\n<div class=\"page\" title=\"Page 1\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"informacion-general\" class=\"tab-pane rl_tabs-pane nn_tabs-pane orange active\" role=\"tabpanel\" aria-labelledby=\"tab-informacion-general\" aria-hidden=\"false\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"informacion-general\" class=\"tab-pane rl_tabs-pane nn_tabs-pane orange active\" role=\"tabpanel\" aria-labelledby=\"tab-informacion-general\" aria-hidden=\"false\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"informacion-general\" class=\"tab-pane rl_tabs-pane nn_tabs-pane active orange\" role=\"tabpanel\" aria-labelledby=\"tab-informacion-general\" aria-hidden=\"false\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"informacion-general\" class=\"tab-pane rl_tabs-pane nn_tabs-pane active orange\" role=\"tabpanel\" aria-labelledby=\"tab-informacion-general\" aria-hidden=\"false\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"informacion-general\" class=\"tab-pane rl_tabs-pane nn_tabs-pane active orange\" role=\"tabpanel\" aria-labelledby=\"tab-informacion-general\" aria-hidden=\"false\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"informacion-general\" class=\"tab-pane rl_tabs-pane nn_tabs-pane active orange\" role=\"tabpanel\" aria-labelledby=\"tab-informacion-general\" aria-hidden=\"false\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"informacion-general\" class=\"tab-pane rl_tabs-pane nn_tabs-pane active orange\" role=\"tabpanel\" aria-labelledby=\"tab-informacion-general\" aria-hidden=\"false\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"informacion-general\" class=\"tab-pane rl_tabs-pane nn_tabs-pane active orange\" role=\"tabpanel\" aria-labelledby=\"tab-informacion-general\" aria-hidden=\"false\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"informacion-general\" class=\"tab-pane rl_tabs-pane nn_tabs-pane active orange\" role=\"tabpanel\" aria-labelledby=\"tab-informacion-general\" aria-hidden=\"false\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"informacion-general\" class=\"tab-pane rl_tabs-pane nn_tabs-pane active orange\" role=\"tabpanel\" aria-labelledby=\"tab-informacion-general\" aria-hidden=\"false\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"informacion-general\" class=\"tab-pane rl_tabs-pane nn_tabs-pane active orange\" role=\"tabpanel\" aria-labelledby=\"tab-informacion-general\" aria-hidden=\"false\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"informacion-general\" class=\"tab-pane rl_tabs-pane nn_tabs-pane active orange\" role=\"tabpanel\" aria-labelledby=\"tab-informacion-general\" aria-hidden=\"false\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"informacion-general\" class=\"tab-pane rl_tabs-pane nn_tabs-pane orange active\" role=\"tabpanel\" aria-labelledby=\"tab-informacion-general\" aria-hidden=\"false\">\n<p>The <strong>IMI Joint Undertaking<\/strong> is a public-private partnership between the <em>EU<\/em> and the <em>European Federation of Pharmaceutical Industry Associations<\/em> (EFPIA). The two partners are equally represented on the board of directors, the main decision-making body of the joint venture. The board of directors is advised by committees in which the scientific community, the EU governments and the countries associated with the Horizon 2020 initiative are represented. In addition, it receives input from other groups created to coordinate the company's tasks common in specific fields.<\/p>\n<p>The main objectives of the Joint Undertaking and its priority areas of research are determined in the Regulation establishing the Joint Undertaking and in the Strategic Research Programme. IMI relies on them to launch calls for proposals on specific research topics. The evaluation of the proposals is in the hands of external experts.<\/p>\n<p><em>Beneficiaries<\/em><\/p>\n<p>-Patients, who can influence the investigation of their ailments. In the long term, both they and society as a whole will benefit from faster access to better and safer medicines,<br \/>\n-university researchers and SMEs, which obtain funds for research,<br \/>\n-pharmaceutical companies, who acquire knowledge and tools to improve their research and development activities,<br \/>\n- and to all the participants in the projects, who benefit from the technical knowledge of the other partners and from the possibility of transforming scientific discoveries into useful tools, thus promoting the development of medicines.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<footer class=\"article-footer\"><\/footer>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<hr \/>\n<p><strong>Procedure<\/strong><\/p>\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"procedimiento\" class=\"tab-pane rl_tabs-pane nn_tabs-pane orange active\" role=\"tabpanel\" aria-labelledby=\"tab-procedimiento\" aria-hidden=\"false\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"procedimiento\" class=\"tab-pane rl_tabs-pane nn_tabs-pane orange active\" role=\"tabpanel\" aria-labelledby=\"tab-procedimiento\" aria-hidden=\"false\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"procedimiento\" class=\"tab-pane rl_tabs-pane nn_tabs-pane orange active\" role=\"tabpanel\" aria-labelledby=\"tab-procedimiento\" aria-hidden=\"false\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"procedimiento\" class=\"tab-pane rl_tabs-pane nn_tabs-pane orange active\" role=\"tabpanel\" aria-labelledby=\"tab-procedimiento\" aria-hidden=\"false\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"procedimiento\" class=\"tab-pane rl_tabs-pane nn_tabs-pane orange active\" role=\"tabpanel\" aria-labelledby=\"tab-procedimiento\" aria-hidden=\"false\">\n<div>\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"procedimiento\" class=\"tab-pane rl_tabs-pane nn_tabs-pane orange active\" role=\"tabpanel\" aria-labelledby=\"tab-procedimiento\" aria-hidden=\"false\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"procedimiento\" class=\"tab-pane rl_tabs-pane nn_tabs-pane orange active\" role=\"tabpanel\" aria-labelledby=\"tab-procedimiento\" aria-hidden=\"false\">\n<p>The IMI Joint Undertaking improves and accelerates the development of medicines, supporting open collaboration in research tasks to address common challenges. It finances collaborative projects that bring together all the parties involved in health research: universities, pharmaceutical and other industries, small and medium-sized companies, patient organisations, drug regulatory authorities.<\/p>\n<p>The IMI Joint Undertaking improves and accelerates the development of medicines, supporting open collaboration in research tasks to address common challenges. It finances collaborative projects that bring together all the parties involved in health research: universities, pharmaceutical and other industries, small and medium-sized companies, patient organisations, drug regulatory authorities.<\/p>\n<p>This approach brings results in areas where there are no effective treatments (for example, dementia) or that have a major impact on public health (such as diabetes or antibiotic resistance). The Joint Undertaking for the Innovative Medicines Initiative also carries out projects on cross-cutting themes such as medicine safety and big data.<\/p>\n<p>The selected projects receive joint support from the EU and EFPIA. The EU allocates funds to universities, SMEs and patient organisations. The EFPIA companies do not receive EU funding through the IMI 2 Joint Undertaking, but rather make in-kind contributions to the projects (to which they contribute, for example, the working hours of their researchers or access to facilities). and resources).<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<hr \/>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<p><strong>Contact details<\/strong><\/p>\n<div class=\"ecl-site-header-standardised__banner\">\n<div class=\"ecl-container\">\n<div class=\"ecl-site-header-standardised__site-name\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"procedimiento\" class=\"tab-pane rl_tabs-pane nn_tabs-pane orange active\" role=\"tabpanel\" aria-labelledby=\"tab-procedimiento\" aria-hidden=\"false\">\n<div class=\"tab-content\">\n<div id=\"informacion-general\" class=\"tab-pane rl_tabs-pane nn_tabs-pane active orange\" role=\"tabpanel\" aria-labelledby=\"tab-informacion-general\" aria-hidden=\"false\">\n<div id=\"contacto\" class=\"tab-pane rl_tabs-pane nn_tabs-pane orange\" role=\"tabpanel\" aria-labelledby=\"tab-contacto\" aria-hidden=\"true\">\n<section class=\"article-body\">\n<div class=\"rl_tabs nn_tabs outline_handles outline_content top align_left has_effects\" role=\"presentation\">\n<div class=\"tab-content\">\n<div id=\"procedimiento\" class=\"tab-pane rl_tabs-pane nn_tabs-pane orange active\" role=\"tabpanel\" aria-labelledby=\"tab-procedimiento\" aria-hidden=\"false\">\n<div>\n<div>\n<div>\n<p><strong>IMI Joint Undertaking<\/strong><br \/>\nAvenue de la Toison d'Or 56-60<br \/>\n1060 Bruxelles \/ Brussel<br \/>\nBelgique<br \/>\nTel: +32 2 221 81 81<br \/>\n<span id=\"cloak8b25191808a119d0d971ba2a01f9ea12\"><a href=\"mailto:infodesk@imi.europa.eu\">infodesk@imi.europa.eu<\/a><\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>The Innovative Medicines Initiative Joint Undertaking (IMI Joint Undertaking) supports collaborative research to improve the entire development process and make it more efficient, accelerating patients' access to better and safer medicines. Its function is none other than to promote the development of medicines, facilitating open collaboration in research. CALLS FOR PROPOSALS Calls are published regularly [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1674,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"activitypub_content_warning":"","activitypub_content_visibility":"","activitypub_max_image_attachments":4,"activitypub_interaction_policy_quote":"anyone","activitypub_status":"","footnotes":""},"categories":[91,87],"tags":[510,509,117,471,115,113],"class_list":["post-1685","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-public-health-and-consumers","category-research-innovation-competitiveness-and-smes","tag-innovatives-medicines-innitiative","tag-medicines","tag-member-countries","tag-rdt","tag-smes","tag-universities"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-08-05 11:18:42","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/www.guiafc.es\/en\/wp-json\/wp\/v2\/posts\/1685","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.guiafc.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.guiafc.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.guiafc.es\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.guiafc.es\/en\/wp-json\/wp\/v2\/comments?post=1685"}],"version-history":[{"count":7,"href":"https:\/\/www.guiafc.es\/en\/wp-json\/wp\/v2\/posts\/1685\/revisions"}],"predecessor-version":[{"id":1694,"href":"https:\/\/www.guiafc.es\/en\/wp-json\/wp\/v2\/posts\/1685\/revisions\/1694"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.guiafc.es\/en\/wp-json\/wp\/v2\/media\/1674"}],"wp:attachment":[{"href":"https:\/\/www.guiafc.es\/en\/wp-json\/wp\/v2\/media?parent=1685"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.guiafc.es\/en\/wp-json\/wp\/v2\/categories?post=1685"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.guiafc.es\/en\/wp-json\/wp\/v2\/tags?post=1685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}